BRAF and colonic neoplasm: A recent study based on the analysis of molecular markers in two large cohorts of patients provided some evidence in favor of a regional distribution of molecular abnormalities in colon cancer; particularly, the frequencies of CIMP-high, MSI-high and BRAF mutations increased in a statistically linear fashion from the rectum to the ascending colon [97].